These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 18261364

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin.
    Kim YC, Oh EY, Kim SH, Lee MG.
    Biopharm Drug Dispos; 2006 Mar; 27(2):85-92. PubMed ID: 16312011
    [Abstract] [Full Text] [Related]

  • 6. Effect of CYP3A1(23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus.
    Kim YC, Lee JH, Kim SH, Lee MG.
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2528-32. PubMed ID: 15917564
    [Abstract] [Full Text] [Related]

  • 7. Telithromycin pharmacokinetics in rat model of diabetes mellitus induced by alloxan or streptozotocin.
    Lee JH, Lee MG.
    Pharm Res; 2008 Aug; 25(8):1915-24. PubMed ID: 18478316
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of omeprazole after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
    Lee DY, Lee I, Lee MG.
    Int J Pharm; 2007 Feb 07; 330(1-2):37-44. PubMed ID: 16997515
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic interaction between oltipraz and omeprazole in rats: Competitive inhibition of metabolism of oltipraz by omeprazole via CYP1A1 and 3A2, and of omeprazole by oltipraz via CYP1A1/2, 2D1/2, and 3A1/2.
    Lee DY, Kim JW, Lee MG.
    Eur J Pharm Sci; 2007 Dec 07; 32(4-5):328-39. PubMed ID: 17935951
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of phenytoin and its metabolite, 4'-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin.
    Kim YC, Kang HE, Lee MG.
    Biopharm Drug Dispos; 2008 Jan 07; 29(1):51-61. PubMed ID: 18022993
    [Abstract] [Full Text] [Related]

  • 14. Changes in metformin pharmacokinetics after intravenous and oral administration to rats with short-term and long-term diabetes induced by streptozotocin.
    Choi YH, Lee DC, Lee I, Lee MG.
    J Pharm Sci; 2008 Dec 07; 97(12):5363-75. PubMed ID: 18393297
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Strategies for preclinical pharmacokinetic investigation in streptozotocin-induced diabetes mellitus (DMIS) and alloxan-induced diabetes mellitus (DMIA) rat models: case studies and perspectives.
    Srinivas NR.
    Eur J Drug Metab Pharmacokinet; 2015 Mar 07; 40(1):1-12. PubMed ID: 24596068
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
    Baek HW, Bae SK, Lee MG, Sohn YT.
    J Pharm Sci; 2006 Nov 07; 95(11):2452-62. PubMed ID: 16886191
    [Abstract] [Full Text] [Related]

  • 19. Faster clearance of mirodenafil in rats with acute renal failure induced by uranyl nitrate: contribution of increased protein expression of hepatic CYP3A1 and intestinal CYP1A1 and 3A1/2.
    Choi YH, Lee YS, Kim TK, Lee BY, Lee MG.
    J Pharm Pharmacol; 2009 Oct 07; 61(10):1325-32. PubMed ID: 19814864
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.